Access to new therapies

Science and the pharmaceutical industry are currently researching a whole range of new therapies. These new therapies are produced precisely for the respective disease and the respective patient and are therefore usually highly effective, but also very expensive. You will now hear different views on access to such therapies.

Please indicate how much you agree with each view.

in % inhabitants aged 18 and over